07:06 AM EDT, 05/05/2025 (MT Newswires) -- BioNTech SE ( BNTX ) reported a Q1 loss Monday of 1.73 euros ($1.96) per diluted share, wider than a loss of 1.31 euros a year earlier.

Analysts polled by FactSet expected a loss of 1.84 euros.

Revenue for the quarter ended March 31 was 182.8 million euros compared with 187.6 million euros a year earlier.

Analysts surveyed by FactSet expected 198.8 million euros.

The company maintained its 2025 revenue guidance of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.05 billion euros.